Login / Signup

Efficacy and safety of enflicoxib for treatment of canine osteoarthritis: A 6-week randomised, controlled, blind, multicentre clinical trial.

Marta SalichsLlorenç BadiellaPatxi SarasolaJosep M Homedes
Published in: The Veterinary record (2021)
Enflicoxib administered weekly for 6 weeks, at 4 mg/kg PO with an initial loading dose of 8 mg/kg, is efficacious and safe for the treatment of canine osteoarthritis.
Keyphrases
  • clinical trial
  • rheumatoid arthritis
  • knee osteoarthritis
  • randomized controlled trial